PL405046A1 - Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie - Google Patents

Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie

Info

Publication number
PL405046A1
PL405046A1 PL405046A PL40504613A PL405046A1 PL 405046 A1 PL405046 A1 PL 405046A1 PL 405046 A PL405046 A PL 405046A PL 40504613 A PL40504613 A PL 40504613A PL 405046 A1 PL405046 A1 PL 405046A1
Authority
PL
Poland
Prior art keywords
mmp
activity
biosensor
fret
application
Prior art date
Application number
PL405046A
Other languages
English (en)
Inventor
Michał Stawarski
Jakub Włodarczyk
Leszek Kaczmarek
Original Assignee
Instytut Biologii Doświadczalnej Im. Marcelego Nenckiego Pan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biologii Doświadczalnej Im. Marcelego Nenckiego Pan filed Critical Instytut Biologii Doświadczalnej Im. Marcelego Nenckiego Pan
Priority to PL405046A priority Critical patent/PL405046A1/pl
Priority to EP14789607.0A priority patent/EP3033621A2/en
Priority to CN201480047715.0A priority patent/CN105593686A/zh
Priority to PCT/IB2014/063883 priority patent/WO2015022646A2/en
Priority to JP2016533982A priority patent/JP2016526926A/ja
Priority to US14/911,821 priority patent/US9914955B2/en
Publication of PL405046A1 publication Critical patent/PL405046A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Wynalazek dotyczy genetycznie zakodowanego, wykorzystującego zjawisko FRET biosensora do monitorowania aktywności metaloproteazy macierzy zewnątrzkomórkowej 9 (MMP-9). MMP-9 jest zewnątrzkomórkową endopeptydazą zaangażowaną zarówno w procesy fizjologiczne i patologiczne. Zakotwiczony w błonie komórkowej, genetycznie zakodowany, wykorzystujący zjawisko FRET, biosensor pozwala na badanie aktywności proteolitycznej MMP-9 z wysoką rozdzielczością czasowo-przestrzenną bezpośrednio w miejscu aktywności MMP-9 na komórce. Funkcjonalność biosensora, zarówno in vitro i in vivo w żywych komórkach została wykazana przy pomocy analizy ratiometrycznej cięcia biosensora przez oczyszczoną auto-aktywującą zmutowaną MMP-9.
PL405046A 2013-08-12 2013-08-12 Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie PL405046A1 (pl)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PL405046A PL405046A1 (pl) 2013-08-12 2013-08-12 Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie
EP14789607.0A EP3033621A2 (en) 2013-08-12 2014-08-12 Genetically encoded fret-based mmp-9 activity biosensor and use thereof
CN201480047715.0A CN105593686A (zh) 2013-08-12 2014-08-12 遗传编码的基于fret的mmp-9活性生物传感器及其用途
PCT/IB2014/063883 WO2015022646A2 (en) 2013-08-12 2014-08-12 Genetically encoded fret-based mmp-9 activity biosensor and use thereof
JP2016533982A JP2016526926A (ja) 2013-08-12 2014-08-12 遺伝子的にコードしたｆｒｅｔベースのｍｍｐ−９活性バイオセンサおよびその使用
US14/911,821 US9914955B2 (en) 2013-08-12 2014-08-12 Genetically encoded FRET-based MMP-9 activity biosensor and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL405046A PL405046A1 (pl) 2013-08-12 2013-08-12 Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie

Publications (1)

Publication Number Publication Date
PL405046A1 true PL405046A1 (pl) 2015-02-16

Family

ID=51795665

Family Applications (1)

Application Number Title Priority Date Filing Date
PL405046A PL405046A1 (pl) 2013-08-12 2013-08-12 Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie

Country Status (6)

Country Link
US (1) US9914955B2 (pl)
EP (1) EP3033621A2 (pl)
JP (1) JP2016526926A (pl)
CN (1) CN105593686A (pl)
PL (1) PL405046A1 (pl)
WO (1) WO2015022646A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105572088A (zh) * 2016-01-14 2016-05-11 刘伟 一种检测mmp-9功能的fret生物传感器及其构建方法与应用
KR102018249B1 (ko) * 2017-04-04 2019-09-10 한양대학교 산학협력단 프로테아제 활성 분석용 프로브 및 이를 이용한 분석 방법
CN112567245A (zh) * 2018-08-28 2021-03-26 Jl美迪乐博斯公司 检测目标物质的方法和试剂盒
KR102659088B1 (ko) * 2019-11-18 2024-04-24 서울대학교병원 Mmp 센서 기반의 실시간 구형 구축 모니터링과 치료가 가능한 유방 재건용 조직 확장기 및 이와 연계된 환자 정보 시스템

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7935801B2 (en) * 2005-05-20 2011-05-03 The Governors Of The University Of Alberta Teal fluorescent proteins
NO20053354D0 (no) * 2005-07-11 2005-07-11 Amersham Health As Optical imaging contrast agent.
US8481272B2 (en) * 2006-08-04 2013-07-09 Georgia State University Research Foundation, Inc. Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
CN100557031C (zh) * 2006-12-27 2009-11-04 华中科技大学 检测基质金属蛋白酶活性的多核苷酸序列
WO2009035476A1 (en) * 2007-09-14 2009-03-19 Biosentinel, Llc Resonance energy transfer assay with cleavage sequence and spacer
WO2010017203A1 (en) * 2008-08-04 2010-02-11 The Board Of Trustees Of The University Of Illinois Fret-based membrane-type 1 matrix metalloproteinase biosensor and methods for using the same
JP2012177549A (ja) * 2009-06-24 2012-09-13 Hokkaido Univ 蛍光温度プローブおよびそれを用いた温度測定装置
CA2841249C (en) * 2011-07-29 2023-09-26 Avelas Biosciences, Inc. Selective delivery molecules and methods of use

Also Published As

Publication number Publication date
US9914955B2 (en) 2018-03-13
US20160194681A1 (en) 2016-07-07
WO2015022646A3 (en) 2015-05-07
EP3033621A2 (en) 2016-06-22
JP2016526926A (ja) 2016-09-08
WO2015022646A2 (en) 2015-02-19
WO2015022646A4 (en) 2015-06-25
CN105593686A (zh) 2016-05-18

Similar Documents

Publication Publication Date Title
CY1121327T1 (el) Τροποποιημενα αντισωματα anti-il-23p19
EP2019587A4 (en) PROTEASE DETECTION AND PROTEASE ACTIVITY USING SINGLE NANOCROUTING SEN PROBE
PL405046A1 (pl) Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie
MX2015006757A (es) Método para la evaluación de la presencia de o riesgo de tumores de colon.
RU2012105922A (ru) Дифференцирование человеческих эмбриональных стволовых клеток
CO6551732A2 (es) Dispositivo portatil de monitorizaciòn de la coagulación y método de evaluación de la respuesta de coagulación
ATE509570T1 (de) Analytisches hilfsmittel mit lanzette und testelement
GB2476842A8 (en) Forceps
MX348392B (es) Sistemas y metodos para diagnostico de la salud.
ATE494834T1 (de) Säuglingsmonitor
ATE498358T1 (de) Sensoranordnung mit leitfähiger brücke
BR112013014003A2 (pt) Métodos de redução de produção de sebo na pele
PH12013502490A1 (en) Lysyl oxidase-like 2 assay and methods of use thereof
DE60231814D1 (de) Diagnostische marker für ischämie und mortalitätsrisiken
MA38042B2 (fr) Méthylglyoxal en tant que marqueur du cancer
BR112014031934A8 (pt) Método com base em euglobulina para determinar a atividade biológica de defibrotide
WO2007084397A3 (en) Processing of slpi by chymase
CO6430490A2 (es) Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral
BR112013031431A2 (pt) método para o diagnóstico da doença de gaucher
BR112014029808A2 (pt) método para testar o efeito de uma etapa de produção ou etapas de produção ou a eficácia de uma etapa de purificação ou etapas de purificação na presença ou na natureza de moléculas pró-inflamatórias em polímeros de glicose ou hidrolisados dos mesmos; e método otimizado para produzir ou purificar polímeros de glicose ou hidrolisados dos mesmos
UY29777A1 (es) Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos del sueno en pacientes con depresión.
CY1111602T1 (el) ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΑΝΙΧΝΕΥΣΗ ΤΗΣ ΔΡΑΣΤΙΚΟΤΗΤΑΣ IN VIVO ΤΗΣ ΝΕΥΡΟΤΡΥΨΙΝΗΣ, ΧΡΗΣΗ ΤΗΣ ΜΕΘΟΔΟΥ ΚΑΙ ΧΡΗΣΗ TOY C-ΤΕΡΜΑΤΙΚΟΥ 22-kDa ΘΡΑΥΣΜΑΤΟΣ ΤΗΣ ΑΓΡΙΝΗΣ ΩΣ ΒΙΟΔΕΙΚΤΗ ΕΙΣ ΤΗΝ ΔΙΑΓΝΩΣΗ ΚΑΙ ΠΑΡΑΚΟΛΟΥΘΗΣΗ ΔΙΑΤΑΡΑΧΩΝ ΠΟΥ ΕΧΟΥΝ ΣΧΕΣΗ ΜΕ ΝΕΥΡΟΤΡΥΨΙΝΗ
BR112015015574A2 (pt) método e sistema de diagnóstico e monitoramento de exame cardiovascular
CL2009001323A1 (es) Metodo que mide estabilidad de antigeno que comprende obtener una primera medicion por cromatografia liquida (hplc) del antigeno en una muestra, obtener una segunda medicion por hplc en una segunda muestra, y cuantificar los cambios de la segunda medicion en comparacion a la primera por hplc.
PL407244A1 (pl) Bioczujnik elektrochemiczny do wykrywania białka S100B